Verdiva Bio
Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
About
Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative treatments for obesity and cardiometabolic diseases. Their pipeline includes both oral and injectable therapies designed to enhance efficacy, improve patient convenience, and achieve better long-term outcomes, with a particular emphasis on patient-friendly options like once-weekly dosing. The company leverages advancements in gut-brain biology to create novel medicines addressing significant unmet medical needs globally. Teams look it up for Biotechnology, Pharmaceuticals, HealthTech.
Frequently asked
What does Verdiva Bio do?
Verdiva Bio is a Biotechnology company that offers Services. Teams look it up for Pharmaceuticals, HealthTech, Medical Devices. It is based in San Diego, United States and was founded in 2021. Public records show about 74 people and $170M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Verdiva Bio raised?
Verdiva Bio has raised a total of $170M in funding. The most recent round on record is Series B.
Where is Verdiva Bio headquartered?
Verdiva Bio is headquartered in San Diego, United States.
When was Verdiva Bio founded?
Verdiva Bio was founded in 2021.
What industry does Verdiva Bio operate in?
Verdiva Bio operates in Biotechnology, Pharmaceuticals, HealthTech, Medical Devices, Biotech.
How many employees does Verdiva Bio have?
Verdiva Bio has approximately 74 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.